HN2301*
CD19
in Vivo CAR-T
SLE
SSc, IMM, MG
PIPELINE
SCROLL
Our Pipeline
Broad Pipeline of Novel Preclinical and Clinical Stage Assets
In vivo CAR-T / TCE
In vivo
reprogramming
Infectious
diseases
HN2605
Dual Targeted
in Vivo CAR-T
Autoimmune Disorders
HN2606
mRNA
Encoded Trispecific TCE
Autoimmune Disorders
HN2401
Undisclosed
in Vivo Reprogramming
T Cell Driven Immunological Disorders
HN2403
Gene Insertion
in Vivo CAR-T
Autoimmune Disorders
Infectious Diseases
*HN2301 follow-on candidates in development incorporate alternative RNA cargo formats and optimized sequence elements.